RedHill Biopharma Announces Deal To Acquire Global Rebyota And U.S. Clenpiq Commercialization Rights From Ferring For $12M Upfront, Plus Milestones And Tiered Royalties

Benzinga Newsdesk www.benzinga.com Positive 70.7%

Neg 0% Neu 0% Pos 70.7%

Comments

No comments yet. Be the first!